Targeting epigenetic regulation for cancer therapy using small molecule inhibitors
Author:
Publisher
Elsevier
Reference500 articles.
1. A phase Ib/IIa study of the Pan-BET inhibitor ZEN-3694 in combination with enzalutamide in patients with metastatic castration-resistant prostate cancer;Aggarwal;Clinical Cancer Research,2020
2. Phase Ib study of the BET inhibitor GS-5829 as monotherapy and combined with enzalutamide in patients with metastatic castration-resistant prostate cancer;Aggarwal;Clinical Cancer Research,2022
3. Nucleosidic DNA demethylating epigenetic drugs—A comprehensive review from discovery to clinic;Agrawal;Pharmacology & Therapeutics,2018
4. Targeting WDR5: A WINning anti-cancer strategy?;Aho;Epigenet Insights,2019
5. Largazole is a brain-penetrant class I HDAC inhibitor with extended applicability to glioblastoma and CNS diseases;Al-Awadhi;ACS Chemical Neuroscience,2020
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Evolving Treatment Landscape of Medullary Thyroid Cancer;Current Treatment Options in Oncology;2023-11-18
2. Repression of LSD1 potentiates homologous recombination-proficient ovarian cancer to PARP inhibitors through down-regulation of BRCA1/2 and RAD51;Nature Communications;2023-11-16
3. Histone modification: Biomarkers and potential therapies in colorectal cancer;Annals of Human Genetics;2023-09-15
4. Breast cancers as ecosystems: a metabolic perspective;Cellular and Molecular Life Sciences;2023-08-10
5. New insights for gynecological cancer therapies: from molecular mechanisms and clinical evidence to future directions;Cancer and Metastasis Reviews;2023-06-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3